600867.SH
通化东宝
SSE · Healthcare · Drug Manufacturers - General · CN
CNY 7.95
−1.97%Margins
Gross margin
70.9%
EBITDA margin
61.4%
EBIT margin
53.5%
Net margin
40.6%
FCF margin
10.6%
17.1%
Return on equity
15.0%
Return on assets
21.2%
Return on invested capital
0.38x
Asset turnover
CNY 853.1M
Cash from operations
—
Cash per share
Margins, returns on capital and operating efficiency from the latest trailing period · Data as of Mar 1, 2026